We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Immunoassay Analyzer POC Diagnostic Tool for Venous Thromboembolism

By LabMedica International staff writers
Posted on 07 Jun 2011
A compact and cost-effective point of care (POC) immunoassay analyzer offers rapid turnaround times for determination of critical biomarkers, such as D-dimer, and provides a valuable diagnostic tool for ruling out venous thromboembolism (VTE).

The easy-to-use AQT90 FLEX can simultaneously measure cardiac markers, coagulation markers, infection markers, and pregnancy markers from a single sample. More...
No sample preparation is required, and, as a closed tube system, the risk of users coming into contact with blood or waste products is eliminated.

A product of Radiometer (Crawley, United Kingdom), the compact, cost-effective AQT90 FLEX enables clinicians to perform rapid, accurate, POC D-dimer measurements in less than 20 minutes. AQT90 FLEX delivers complete data capture with continuous synchronization of analyzers and laboratory information systems/hospital information systems (LIS/HIS).

The Radiance software solution provides complete remote control that emulates the data control and flow of a central laboratory, with the potential to encompass multiple hospitals within a region.

Reports have estimated that 25,000 people die annually as a result of VTE, and that more than 10,000 lives could be saved if all patients were screened on admission to hospital. Patients with negative D-dimer test results are at very low risk of VTE. Rapid point-of-care testing with the AQT90 FLEX saves time and reduces costs by improving patient flow and decreasing the number of unnecessary procedures requested.

Related Links:

Radiometer


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.